Trial Profile
A placebo-controlled, double-blind, randomized, parallel study of the efficacy and safety of dapoxetine HCl in the treatment of rapid ejaculation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2010
Price :
$35
*
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Registrational; Therapeutic Use
- 24 Mar 2010 Actual patient number (1294) added as reported by ClinicalTrials.gov.
- 12 Sep 2006 Status change
- 19 Nov 2005 New trial record.